Pembrolizumab improves the prognosis for breast cancer regardless of age or menopausal status, according to new research.

Published Date: 20 Mar 2024

Recent findings from the phase 3 clinical trial KEYNOTE-756 demonstrate that patients, regardless of their immunotherapy status, have better outcomes when pembrolizumab is added to chemotherapy before and after breast cancer surgery.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth

2.

Detecting pancreatic cancer through changes in body composition and metabolism

3.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.

4.

The pandemic had little impact on mental health symptoms.

5.

Men over 75 years old may be significantly more likely to commit suicide if they have cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot